Oncocyte Corp Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2017 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Oncocyte Corp annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2017 to Q1 2023.
  • Oncocyte Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was -$28K, a 92.1% increase year-over-year.
  • Oncocyte Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $12.2M, a 66% decline from 2022.
  • Oncocyte Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $35.8M, a 54.3% decline from 2021.
  • Oncocyte Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $78.4M, a 244% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$28K +$327K +92.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 -$355K -$70.2M -101% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $69.9M +$62.3M +824% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $7.57M -$30.3M -80% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $37.9M +$30.1M +388% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q1 2018 $7.77M +$3.79M +95.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $3.98M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.